The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations.

Advertisement Advertisement But any AI-related company attempting to acquire 23andMe would run significant reputational risks. Many people are horrified by the thought that they surrendered their ...

The bankruptcy of genetic-testing company 23andMe puts millions of Americans’ genomic profiles at risk of being sold ... based in or with controlling investments from countries of concern ...

raised concerns with Treasury Secretary Scott Bessent and 23andMe executives over the risk that Chinese companies ... Treasury’s Committee on Foreign Investment in the United States, a panel ...

April 22 (Reuters) - Bankrupt genetic test company 23andMe ... Investment in the United States (CFIUS), an interagency body that vets foreign investments into U.S. companies for national security ...

we are concerned that this trove of sensitive information is at risk of being compromised,” the representatives write. Last year, 23andMe settled a data breach lawsuit for $30 million and filed ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...